Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Andrew Joins Stevenage Bioscience Catalyst As CFO and Interim CEO
PRIVATESep 07, 2026•about 12 hours ago
Position
Chief Financial Officer
Company
Stevenage Bioscience Catalyst
Andrew Andrew
BiotechnologyHealth CareLife Science
Description
Andrew has been appointed as Chief Financial Officer and Interim Chief Executive Officer of Stevenage Bioscience Catalyst. He brings a wealth of experience from his previous roles in the life sciences industry and private equity.
Company Information
Company
Stevenage Bioscience Catalyst
About
Stevenage Bioscience Catalyst is a leading life sciences incubator that supports biotech companies. It provides facilities and resources to help accelerate the development of innovative healthcare solutions. The organization promotes collaboration and development within the life sciences sector.
Don't miss Stevenage Bioscience Catalyst's next move
Get an email the moment Stevenage Bioscience Catalyst changes its leadership, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for Stevenage Bioscience Catalyst's next move